Live: Tuesday, December 17, 2019

1:45 p.m. New York time

I made a number of adjustments to two stock portfolios today.

Growth Portfolio:

Exited AMAT for $60.48 per share, a profit of $2.49. The position showed a 4.3% return over 19 days, or an 83% annual rate. The exit was triggered by analyst’s revisions to their assessments.

Exited CNNE for $37.17 per shares, a profit of $1.90. The position returned 5.4% over 52 days for a +38% annual rate.

I re-entered EBMT, whose trailing stop/loss was trigged yesterday by something rogue. The re-entry debit was $22.08 per share.

I added RS, which appeared on the screening, for a debit of $119.89 per share.

Genetics Portfolio:

I exited GH for $77.64 a share, a $3.39 profit, after it ceased to qualify for the portfolio due to a lowering of Zacks assessment of the stock’s momentum, from A at entry down to C.

I added two symbols: BMY for a $63.73 per share debit, and INCY for a $92.12/share debit.

By Tim Bovee, Portland, Oregon, December 17, 2019


Tim Bovee, Private Trader tracks the analysis and trades of a private trader for his own accounts. Nothing in this blog constitutes a recommendation to buy or sell stocks, options or any other financial instrument. The only purpose of this blog is to provide education and entertainment.

No trader is ever 100 percent successful in his or her trades. Trading in the stock and option markets is risky and uncertain. Each trader must make trading decisions for his or her own account, and take responsibility for the consequences.

Creative Commons License

All content on Tim Bovee, Private Trader by Timothy K. Bovee is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Based on a work at